Verici Dx plc (LON:VRCI – Get Free Report)’s share price traded up 7.2% during trading on Tuesday . The stock traded as high as GBX 0.67 ($0.01) and last traded at GBX 0.67 ($0.01). 1,920,448 shares traded hands during mid-day trading, an increase of 47% from the average session volume of 1,309,116 shares. The stock had previously closed at GBX 0.63 ($0.01).
Verici Dx Price Performance
The company has a 50-day moving average of GBX 0.55 and a two-hundred day moving average of GBX 1.19. The company has a debt-to-equity ratio of 4.64, a current ratio of 4.54 and a quick ratio of 8.49. The stock has a market capitalization of £10.59 million, a PE ratio of -28.00 and a beta of 1.59.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Datavault AI: The New AI Contender Backed by Big Funding
- What Does Downgrade Mean in Investing?
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- What Are Earnings Reports?
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
